+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AbbVie Inc. - Strategy, SWOT and Corporate Finance Report

  • PDF Icon

    SWOT Analysis

  • 50 Pages
  • November 2023
  • MarketLine
  • AbbVie, Inc.
  • ID: 4028790
AbbVie Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AbbVie Inc. (AbbVie or ‘the company’) is a biopharmaceutical company that discovers, develops, manufactures and commercializes drugs for the treatment of chronic and complex diseases. The company develops pharmaceutical products that mainly consist of Humira (adalimumab) and products in therapeutic areas of oncology, metabolic/hormones, endocrinology, and virology. It also provides patient support programs and partners with academic institutions, biotechnology companies and other pharmaceutical companies. The company sells its products directly to distributors, wholesalers, health care facilities, specialty pharmacies, government agencies and independent retailers from the company-owned distribution centers and public warehouses. It has business presence in the US, the UK, Canada, Mexico, European Union, Japan, Brazil, and other countries. The company is headquartered in North Chicago, Illinois, the US.

Scope

  • Detailed information on AbbVie Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting AbbVie Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of AbbVie Inc. including a breakdown and examination of key business segments
  • Intelligence on AbbVie Inc.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about AbbVie Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

  • Gain understanding of AbbVie Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess AbbVie Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on AbbVie Inc.'s business structure, strategy and prospects.

Table of Contents

  • Company Snapshot
  • AbbVie Inc.: Company Overview
  • AbbVie Inc.: Overview and Key Facts
  • AbbVie Inc.: Overview
  • AbbVie Inc.: Key Facts
  • AbbVie Inc.: Key Employees
  • AbbVie Inc.: Key Employee Biographies
  • AbbVie Inc.: Major Products and Services
  • AbbVie Inc.: Management Statement
  • AbbVie Inc.: Locations and Subsidiaries
  • AbbVie Inc.: Key Competitors
  • AbbVie Inc.: Company Analysis
  • AbbVie Inc.: Business Description
  • AbbVie Inc.: SWOT Analysis
  • AbbVie Inc.: SWOT Overview
  • AbbVie Inc.: Strengths
  • AbbVie Inc.: Weaknesses
  • AbbVie Inc.: Opportunities
  • AbbVie Inc.: Threats
  • AbbVie Inc.: Corporate Financial Deals Activity
  • AbbVie Inc.: Financial Deals Overview
  • AbbVie Inc.: Targets and Partners
  • AbbVie Inc.: Top Deals 2019 - 2023YTD*
  • AbbVie Inc.: Advisors
  • AbbVie Inc.: Top Legal Advisors
  • AbbVie Inc.: Top Financial Advisors
  • AbbVie Inc.: Mergers and Acquisitions
  • AbbVie Inc.: Corporate Venturing
  • AbbVie Inc.: Capital Raising
  • AbbVie Inc.: Partnership
  • AbbVie Inc.: Divestments
  • AbbVie Inc.: Private Equity and Ownership
  • AbbVie Inc.: Recent Developments
  • AbbVie Inc.: News and Events Summary
  • AbbVie Inc.: Contracts
  • AbbVie Inc.: Market Developments
  • AbbVie Inc.: Research & Development
  • Appendix
  • Contact Us
  • Methodology
List of Tables
Table 1: AbbVie Inc.: Key Facts
Table 2: AbbVie Inc.: Key Employees
Table 3: AbbVie Inc.: Locations and Subsidiaries
Table 4: AbbVie Inc.: Key Competitors
Table 5: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: AbbVie Inc.: M&A Activity by Geography (TTM*)
Table 7: AbbVie Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: AbbVie Inc.: M&A Average Deal Size - Value (US$m)
Table 9: AbbVie Inc.: Targets and Partners
Table 10: AbbVie Inc.: Top Deals 2019 - 2023YTD*
Table 11: AbbVie Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: AbbVie Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: AbbVie Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: AbbVie Inc.: M&A Activity by Geography (2019 - YTD*2023)
Table 15: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: AbbVie Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: AbbVie Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: AbbVie Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: AbbVie Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: AbbVie Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: AbbVie Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: AbbVie Inc.: Divestments by Geography (2019 - YTD*2023)
Table 23: AbbVie Inc.: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
Table 24: AbbVie Inc.: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
Table 25: AbbVie Inc.: News and Events Summary
Table 26: AbbVie Inc.: Contracts
Table 27: AbbVie Inc.: Market Developments
Table 28: AbbVie Inc.: Research & Development

List of Figures
Figure 1: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AbbVie Inc.: M&A Activity by Geography (TTM*)
Figure 3: AbbVie Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: AbbVie Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: AbbVie Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: AbbVie Inc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: AbbVie Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: AbbVie Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: AbbVie Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: AbbVie Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: AbbVie Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: AbbVie Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: AbbVie Inc.: Divestments by Geography (2019 - YTD*2023)
Figure 15: AbbVie Inc.: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
Figure 16: AbbVie Inc.: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)